Product Information
CHOLESTYRAMINE POWDER is a generic product labeled by Epic Pharma LLC, priced at $0.0946 per GM under NDC 42806026797. Its NADAC has been published 221 times since Mar 9, 2022.
FDA first approved this application on Aug 15, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/9g
Manufacturer
Epic Pharma LLCNDC
42806026797
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA074557FDA Approved
8/15/1996
TE Code
AB
On Market Since
12/15/2021
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE POWDER has been published 221 times since Mar 9, 2022, and over the history we have for it it has declined 38.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0946 per GM |
|---|---|
| All-time high | $0.1623 (May 11, 2022) |
| All-time low | $0.0789 (Nov 20, 2024) |
| 52-week high | $0.0977 |
| 52-week low | $0.0870 |
| Median price | $0.1122 |
| Average price | $0.1147 |
| Largest weekly change | +61.2% (May 22, 2024) |
| Weeks tracked | 221 |
| Tracking since | Mar 9, 2022 |
1W
N/A
1M
N/A
3M
-0.1%
6M
-0.2%
1Y
+8.7%
3Y
-15.7%
5Y
N/A
All
-38.3%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Epic Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cholestyramine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE POWDER?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE POWDER, manufactured by Epic Pharma LLC, is $0.0946 per GM (NDC 42806026797), effective Aug 19, 2026.
How has the price of CHOLESTYRAMINE POWDER changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE POWDER has declined 38.3%. It has been tracked across 221 weekly CMS publications since Mar 9, 2022.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE POWDER?
Since Mar 9, 2022, the NADAC for CHOLESTYRAMINE POWDER has ranged from a low of $0.0789 (Nov 20, 2024) to a high of $0.1623 (May 11, 2022), with a median of $0.1122 per GM.
Are there cheaper alternatives to CHOLESTYRAMINE POWDER?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE POWDER, is $0.0924 per GM — about 2% below CHOLESTYRAMINE POWDER.
Who manufactures CHOLESTYRAMINE POWDER?
CHOLESTYRAMINE POWDER (NDC 42806026797) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.